Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture

Clinical and Experimental Immunology

Volumn 152, Issue 3, 2008, Pages 552-558

  Lindfors, K ^a,b   Blomqvist, T ^a,b   Juuti Uusitalo, K ^a,b   Stenman, S ^a,b   Venalainen J ^c   Maki M ^a,b   Kaukinen, K ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bifidibacterium lactis; Coeliac disease; Gliadin; Lactobacillus fermentum

Indexed keywords

ACTIN; GLIADIN; PROBIOTIC AGENT; PROTEIN ZO1;

ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CELIAC DISEASE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LACTOBACILLUS FERMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHEAT;

BIFIDOBACTERIUM; CACO-2 CELLS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; GLIADIN; HUMANS; INTESTINAL MUCOSA; LACTOBACILLUS FERMENTUM; MEMBRANE PROTEINS; PHOSPHOPROTEINS; PROBIOTICS; TIGHT JUNCTIONS; TRITICUM;

EID: 43349099918     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03635.x     Document Type: Article

References (32)

1. Howdle PR. Gliadin, glutenin or both? The search for the Holy grail in celiac disease. Eur J Gastroenterol Hepatol 2006 18 : 703 6.
2. Dewar DH, Amato M, Ellis HJ et al. The toxicity of high molecular weight glutenin subunits of wheat to patients with celiac disease. Eur J Gastroenterol Hepatol 2006 18 : 483 91.
3. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM. Structural basis for gluten intolerance in celiac sprue. Science 2002 297 : 2275 9.
4. Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol 2002 283 : G996 1003.
5. Sollid LM, Jabri B. Is celiac disease an autoimmune disorder? Curr Opin Immunol 2005 17 : 1 6.
6. Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. J Gastroenterol 2007 102 : 1 6.
7. Maiuri L, Ciacci C, Ricciardelli I et al. Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet 2003 62 : 30 7.
8. Tuckova L, Novotna J, Novak P et al. Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J Leukoc Biol 2002 71 : 625 31.
9. Nikulina M, Habich C, Flohe SB, Scott FW, Kolb H. Wheat gluten causes dendritic cell maturation and chemokine secretion. J Immunol 2004 173 : 1925 31.
10. Hue S, Mention J-J, Monteiro RC et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004 21 : 367 77.
11. Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol 2005 2 : 140 7.
12. Mitea C, Havenaar R, Drijfhout JW, Edens L, Dekking L, Koning F. Efficient degradation of gluten by a prolyl endopeptidase in a gastrointestinal model: implications for celiac disease. Gut 2008 57 : 25 32.
13. Gass J, Bethune MT, Siegel M, Spencer A, Khosla C. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 2007 133 : 472 80.
14. Rollan G, De Angelis M, Gobbetti M, de Valdez GF. Proteolytic activity and reduction of gliadin-like fractions by sourdough lactobacilli. J Appl Microbiol 2005 99 : 1495 502.
15. Di Cagno R, De Angelis M, Lavermicco P et al. Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol 2002 68 : 623 33.
16. Di Cagno R, De Angelis M, Auricchio S et al. Sourdough bread made from wheat and nontoxic flours and strated with selected lactobacilli is tolerated in celiac sprue patients. Appl Environ Microbiol 2004 70 : 1088 96.
17. Gerez CL, Rollan GC, de Valdez GF. Gluten breakdown by lactobacilli and pediococci strains isolated from sourdough. Lett Appl Microbiol 2006 42 : 459 64.
18. Rizzello CG, De Angelis M, Di Cagno R et al. Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Appl Environ Microbiol 2007 73 : 4499 507.
19. Sander GR, Cummins AG, Powell BC. Rapid distruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett 2005 579 : 4851 5.
20. Maiuri L, Ciacci C, Ricciardelli I et al. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology 2005 129 : 1400 13.
21. Barone MV, Gimigliono A, Castoria G et al. Growth factor-like activity of gliadin, an alimentary protein: implications for celiac disease (CD). Gut 2007 56 : 480 8.
22. Li N, DeMarco VG, West CM, Neu J. Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells. J Nutr Biochem 2003 14 : 947 9.
23. Zotta T, Piraino P, Ricciardi A, McSweeney PL, Parente E. Proteolysis in model sourdough fermentation. J Agric Food Chem 2006 54 : 2567 74.
24. De Angelis M, Rizzello CG, Fasano A et al. VSL3# probiotic preparation has the capacity to hydrolyse gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta 2005 1762 : 80 93.
25. Otte JM, Podolsky DK. Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004 286 : G613 26.
26. Bai YH, Pak SC, Lee SH et al. Assessment of a bioactive compound for its potential anti-inflammatory property by tight junction permeability. Phytoter Res 2005 19 : 1009 12.
27. Klingberg TD, Pedersen MH, Cencic A, Budde BB. Application of measurement of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol 2005 71 : 7528 30.
28. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003 52 : 988 97.
29. Cinque B, Di Marzio L, Della Riccia DN et al. Effect of Bifidobacterium infantis on interferon-gamma-induced keratinocyte apoptosis: a potential therapeutic approach to skin immune abnormalities. Int J Immunopathol Pharmacol 2006 19 : 775 86.
30. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007 132 : 562 75.
31. Nurmi JT, Puolakkainen PA, Rautonen NE. Bifidobacterium lactis sp420 up-regulates cyclooxygenase (Cox)-1 and downregulates Cox-2 gene expression in a Caco-2 cell culture model. Nutr Cancer 2005 51 : 83 92.
32. Iezzi A, Ferri C, Mezzetti A, Cipollone F. COX-2: friend or foe? Curr Pharm Des 2007 13 : 1715 21.